Home > Research Areas > Neurological Disease > Schizophrenia
Cat. No. Product name CAS No.
DC11936 TAK-915

A highly potent, selective, brain-penetrating and orally active phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 0.61 nM.

1476727-50-0
DC11878 AMG-579

AMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.

1227067-61-9
DC9935 Basmisanil(RG1662) Featured

Basmisanil is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome.

1159600-41-5
DC8882 Bitopertin

Bitopertin, also known as RG1678, is a potent and selective inhibitor of GlyT1 with an EC50 of 30nM.

845614-11-1
DC9067 Clozapine

Clozapine(HF 1854) is a 5-HT2A/2C and dopamine receptor blocker with Ki values of 21, 170, 170, 230 and 330 nM for D4, D3, D1, D2 and D5 receptors respectively.

5786-21-0
DCAPI1055 Iloperidone (Fanapt)

Iloperidone (Fanapt)

133454-47-4
DC11422 lumateperone Tosylate Featured

Lumateperone Tosylate is a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a SERT blocker (Ki = 61 nM).

1187020-80-9
DC11323 LY354740

LY354740 is an agonist of the group II metabotropic glutamate receptor (mGluR) subtypes mGluR2 and mGluR3 (Kis = 99 and 94 nM, respectively).

176199-48-7
DC7192 LY-404039

LY404039 is an inhibitor for mGluR1(Ki=149 nM) and mGluR2(Ki= 92 nM), which can also inhibit dopamine receptor.

635318-11-5
DC7459 LY500307

LY500307 is a potent, selective estrogen receptor β agonist with EC50 of 0.66 nM, 32-fold selectivity against estrogen receptor α. Phase 2.

533884-09-2
DC9993 MK-8998 Featured

MK-8998 is a novel bioactive compound for the treament of psychiatric disease.

953778-58-0
DC10455 NE-100 Featured

NE100 hydrochloride is a potent and selective σ1 receptor antagonist (Ki = 0.86 nM) that displays > 55-fold selectivity over σ2 receptors and > 6000-fold selectivity over D1,

149409-57-4
DC8583 Asenapine Maleate Featured

Novel psychopharmacologic agent. Displays antagonist activity at 5-HT, dopamine, noradrenalin and histamine receptor subtypes (pKi values are 8.60, 8.40, 10.15, 9.75, 10.46, 8.84, 9.60, 9.94, 8.85, 8.90, 8.84, 9.38, 8.95, 8.93, 8.9, 9.49, 8.91, 9.00 and 8

85650-56-2
DC11937 PF 05180999

PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM.

1394033-54-5
DC7201 PF-2545920(MP-10) Featured

PF-2545920 a highly selective and potent PDE10A inhibitor with an IC50 of 0.37 nM.

898562-94-2
DC7268 Risperidone(R 64 766)

Risperidone(R 64 766) is a serotonin 5-HT2 receptor blocker(Ki= 0.16 nM) and a potent dopamine D2 receptor antagonist(Ki= 1.4 nM).

106266-06-2
DC7945 TAK-063 Featured

TAK-063 is a highly potent, selective and orally active PDE10A inhibitor with IC50 of 0.30 nM; >15000-fold selectivity over other PDEs.

1238697-26-1
DC9157 Trifluoperazine dihydrochloride

Trifluoperazine Dihydrochloride is a potent dopamine D2 receptor inhibitor used as an antipsychotic and an antiemetic.

440-17-5
DCAPI1039 Ziprasidone HCl

Ziprasidone HCl

122883-93-6
Page 1 / Total 1 FirstPrevNextLastGoto